Nefrotoxicidad inducida por medicamentos

  Drug-induced nephrotoxicityThis review includes a description of the different types of drug-induced nephrotoxicity (DIN) according to histopathologicclassification, generation mechanism, clinical presentation and drugs most frequently involved. For this review, a systematicsearch was con...

ver descrição completa

Detalhes bibliográficos
Autores: Calderón-Ospina, Carlos Alberto, Guzmán-Ramírez, Ginna Melissa, Sarmiento-Monroy, Juan Camilo, Gómez-Angulo, Danney Loreyni, Joya-Higuera, Angélica Yasmín, Ríos-Barajas, Luisa Fernanda, Romero-Soler, Jenny Paola, Rosado-Sierra, Katiana Victoria, Soler-Barrera, Jenyffer Nathalie
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2011
País:Colombia
Recursos:Universidad Industrial de Santander
Repositório:Repositorio UIS
Idioma:espanhol
OAI Identifier:oai:noesis.uis.edu.co:20.500.14071/5649
Acesso em linha:https://revistas.uis.edu.co/index.php/revistamedicasuis/article/view/2583
https://noesis.uis.edu.co/handle/20.500.14071/5649
Access Level:Acceso aberto
Descrição
Resumo:  Drug-induced nephrotoxicityThis review includes a description of the different types of drug-induced nephrotoxicity (DIN) according to histopathologicclassification, generation mechanism, clinical presentation and drugs most frequently involved. For this review, a systematicsearch was conducted in the Index Medicus for articles published since 1999, which were selected according to their relevance.The DIN is a finding of major clinical importance due to their high frequency and potential severity, and the lack of preventivemeasures in many cases. The main renal impairments caused by drugs can be classified histopathologically according toaltered renal function. Thus, there is the acute tubular necrosis, interstitial nephritis, glomerular injury and vascular changesthat in turn include thrombotic microangiopathy, atherosclerosis and vasculitis. Finally, some commonly used drugs with highpotential for nephrotoxicity are reviewed, with emphasis on recommendations for clinical use to optimize the renal safety ofthese products. Key words: Drug toxicity. Kidney. Acute renal injury. Chronic renal insufficiency. Medicamentous disease. Secondary effect.